论文部分内容阅读
目的探讨CT引导下肝脏肿瘤射频消融(RFA)治疗中副反应与并发症原因及其防治措施。方法 179例原发性肝癌患者,所有患者均在CT引导下行RFA治疗。肿瘤直径为0.5~4.8cm,行RFA 299例次,结果 255例次(255/299 85.2%)出现副反应,21例次(21/299,7%)出现并发症,未出现死亡病例。结论 CT引导肝肿瘤RFA治疗是安全的,常见副反应为出汗、疼痛、恶心、血压升高、心率下降等,并发症为肝被膜下出血、气胸,经治疗后可痊愈。
Objective To investigate the causes and prevention and treatment of side effects and complications in radiofrequency ablation (RFA) treatment of hepatic tumors under CT guidance. Methods A total of 179 patients with primary liver cancer were treated with CT guided RFA. The diameter of the tumor was 0.5~4.8cm, and 299 cases of RFA were performed. 255 cases (255/299 85.2%) had side reactions and 21 cases (21/299, 7%) had complications. No deaths occurred. Conclusion CT-guided liver tumor RFA is safe, common side effects include sweating, pain, nausea, high blood pressure, and decreased heart rate. Complications include subcoenchymal hemorrhage and pneumothorax, which can be cured after treatment.